Skip to content

PriorSurg - Physical Prehabilitation during Neoadjuvant Therapy in Oncological Surgery

PriorSurg - Physical Prehabilitation during Neoadjuvant Therapy in Oncological Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034644
Enrollment
40
Registered
2024-08-16
Start date
2024-03-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25 C20 C16 C15

Interventions

Group 1: Professionally supervised physical prehabilitation in patients undergoing neoadjuvant therapy followed by oncological surgery

Sponsors

JLU Gießen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Physical training possible, logistics feasible

Exclusion criteria

Exclusion criteria: Training sessions not feasible due to logistical or physical reasons

Design outcomes

Primary

MeasureTime frame
VO2peak: Changes in the V02peak values (spiroergometry) from the time of recruitment till 3±2nd preoperative day

Secondary

MeasureTime frame
1. General Outcomes - Patient characteristics - Laboratory and clinical routine parameters - Length of hospital stay - Comorbidities / risk calculation 2. Sports Therapy and Exercise Physiology Outcomes - Drop-out rate, participant compliance (feasibility of the study) - Recruitment rate ([number of patients meeting inclusion criteria] / [recruited patients]) - Compliance / drop-out rate ([recruited patients] / [patients who completed the program]) - Adherence rate ([number of planned training sessions] / [completed training sessions]) - Reasons for drop-out / non-participation - Maximum strength - Training volume and intensity - Assessment of physical activity (self-reported International Physical Activity Questionnaire [IPAQ]) “Fitness watches” upon inclusion (physical activity, heart rate variability) - 6-minute walk distance - Cardiopulmonary exercise testing - Bioelectrical impedance analysis (Instrumental) Activities of daily living (ADL) - Composition of T-cell subpopulations, T-cell function (mitochondrial respiration, proliferation, activation, measurement of immunosenescence markers and inflammatory surface markers using flow cytometry) - Measurement of a panel of inflammatory serum cytokines before and after prehabilitation using multiplex ELISA 3. Surgical-Anesthesiological Outcomes - Perioperative hemodynamics & catecholamine requirement (PICCO monitoring instead of arterial blood pressure measurement as part of standard care), determination of mean arterial pressure - Duration and characteristics of surgery - Cardiac and pulmonary function tests (transthoracic echocardiogram and lung function) - Postoperative complication rate (according to Clavien-Dindo classification), Comprehensive Complication Index, surgical site infections according to WHO - Length of stay in intensive care unit, duration of ventilation, need for analgesics (PCA pump, VAS assessment), organ replacement therapy, Horowitz index, fluid volume - Postopera

Countries

Germany

Contacts

Public ContactMartin;Jacqueline Reichert;Braun

Uniklinikum Gießen;Universitätsklinikum Gießen, Klinik für Allgemein-, Viszeral-, Thorax- und Transplantationschrirugie

martin.reichert@chiru.med.uni-giessen.de;jacqueline.braun@chiru.med.uni-giessen.de0641-98544701;+4964198544701

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026